We are live on ! Find out more
VTGN icon

VistaGen Therapeutics
VTGN

104 hedge funds and large institutions have $360M invested in VistaGen Therapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 29 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 12

21% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 29

3% more funds holding

Funds holding: 101 → 104 (+3)

0.12% more ownership

Funds ownership: 2.15% → 2.27% (+0.12%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

7% less capital invested

Capital invested by funds: $387M → $360M (-$26.5M)

93% less call options, than puts

Call options by funds: $50K | Put options by funds: $704K

Holders
104
Holders Change
+3
Holders Change %
+2.97%
% of All Funds
1.82%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
18
Increased
35
Reduced
29
Closed
12
Calls
$50K
Puts
$704K
Net Calls
-$654K
Net Calls Change
-$654K

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$13.9M
2
CC
Commodore Capital
New York
+$5.19M
3
Goldman Sachs
Goldman Sachs
New York
+$3.01M
4
EGI
EAM Global Investors
California
+$1.84M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.39M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$4.51M
2
IC
Ikarian Capital
Texas
-$915K
3
SFM
Sphera Funds Management
Israel
-$741K
4
SB
Samsara BioCapital
California
-$707K
5
SSA
Schonfeld Strategic Advisors
New York
-$554K
Name Holding Trade Value Shares
Change 		Change in
Stake
SWM
101
Spire Wealth Management
Virginia
$2K +$1.74K +20 New
Jane Street
102
Jane Street
New York
– -$521K -5,522 Closed
MIM
103
Monashee Investment Management
Massachusetts
– -$495K -5,233 Closed
Renaissance Technologies
104
Renaissance Technologies
New York
– -$323K -3,421 Closed
ACM
105
ACT Capital Management
Pennsylvania
– -$315K -3,333 Closed
SO
106
STRS Ohio
Ohio
– -$139K -1,477 Closed
QSS
107
Quantitative Systematic Strategies
Florida
– -$92K -976 Closed
William Blair & Company
108
William Blair & Company
Illinois
– -$38K -407 Closed
X
109
Xponance
Pennsylvania
– -$33K -349 Closed
Fidelity Investments
110
Fidelity Investments
Massachusetts
– -$7.21K -83 Closed
PSIWM
111
Paradigm Strategies in Wealth Management
Minnesota
– -$3K -33 Closed
AWM
112
Atticus Wealth Management
Florida
– -$2K -23 Closed
GKWIM
113
Gerber Kawasaki Wealth & Investment Management
California
– +$435 +5 New
JWM
114
Jackson Wealth Management
Florida
– +$8.34K +96 +22%
1 2 3 4
5

VTGN Hedge Fund Activity: Q3 2021 in Review

104 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in VistaGen Therapeutics (VTGN) for Q3 2021, worth a combined $360M — down 6.8% from $387M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new VTGN positions and 12 closed out — a net gain of 6 holders — while 35 added to existing stakes and 29 trimmed.

The largest buyer was State Street, adding an estimated $13.9M. The largest seller was OrbiMed, cutting an estimated $4.51M.

  • 104 institutional investors held VistaGen Therapeutics (VTGN) as of Q3 2021, up from 101 in Q2 2021.
  • Funds reported $360M of VistaGen Therapeutics stock for Q3 2021, down 6.8% quarter-over-quarter.
  • 18 funds opened new VistaGen Therapeutics positions in Q3 2021 and 12 closed out, a net change of +6 holders.
  • The largest VistaGen Therapeutics buyer in Q3 2021 was State Street, an estimated $13.9M added.
  • The largest VistaGen Therapeutics seller in Q3 2021 was OrbiMed, an estimated $4.51M sold.

Based on aggregated 13F filings for Q3 2021.